CURASIGHT A/S
CVRCVR number35249389
Core data
Name | CURASIGHT A/S |
Address | Ole Maaløes Vej 3, 2200, København N |
Founded | May 22, 2013 |
| 6 / 3 | |
Locations (P-units) | 1View locations |
Website | https://curasight.com/ |
VAT registered | |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | CURASIGHT A/S |
Address | Ole Maaløes Vej 3, 2200, København N |
Founded | May 22, 2013 |
| 6 / 3 |
Locations (P-units) | 1View locations |
Website | https://curasight.com/ |
VAT registered | |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of CURASIGHT A/S
Get an email when we detect changes to financial reports, ownership, management or property trades. Save yourself checking the company again.
Free account
Description
Curasight A/S is a clinical-stage radiopharmaceutical company based in Copenhagen, Denmark, developing uTREAT®, a first-in-class uPAR-targeted radioligand therapy (RLT) platform designed to treat aggressive solid tumors.
Financials
Company financials
| Reporting period | 2025DKK | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross profit | -49,676,000 | ||||||||
| Operating profit | -55,592,000 | ||||||||
| Profit before tax | -58,730,000 | ||||||||
| Net income | -53,230,000 | ||||||||
| Total assets | 50,055,000 | ||||||||
| Equity | 17,936,000 | ||||||||
| Avg. employees | 4 | ||||||||
2017–2025 Unlock financial history | |||||||||
Datapublica Risk Score
Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
0 · Low100 · High
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
People
| Person | Roles | Titles |
|---|---|---|
| Andreas Kjær | Roles Board | TitlesNÆSTFORMAND |
| Kirsten Aarup Drejer | Roles Board | TitlesFORMAND |
| Ulrich Alexander Krasilnikoff | Roles BoardManagement | TitlesBESTYRELSESMEDLEM • ADM. DIR. |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab | AuditorKristian Højgaard Carlsen | RoleState Authorised Public Accountant | FromMay 11, 2026 |
| PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab | AuditorSøren Ørjan Jensen | RoleState Authorised Public Accountant | FromMay 11, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership25–33.32 % | Voting rights25 % | FromSep 10, 2026 | |
Unknown Other Participant | Ownership15–19.99 % | Voting rights15 % | FromJun 2, 2025 |
Child companies
| Company | Ownership | Voting rights | From | To |
|---|---|---|---|---|
| Ownership50–66.66 % | Voting rights50 % | FromFeb 10, 2022 | ToAug 17, 2022 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| 🇳🇱Curium Netherlands B.V | Ownership through Direct | 15–19.99 % |
| Andreas Kjær | Ownership through | 12.5–22.22 % |
| Amalie Christine Lebech Kjær | Ownership through | 6.25–11.11 % |
| Anna Sophie Lebech Kjær | Ownership through | 6.25–11.11 % |
| Peter Nicolaj Krasilnikoff | Ownership through | 5–8.33 % |
| Susanne Marthine Bennedsgaard Krasilnikoff | Ownership through | 3.12–7.41 % |
| Ulrich Alexander Krasilnikoff | Ownership through | 3.12–7.41 % |